HEADER LYASE/LYASE INHIBITOR 20-JAN-11 3QEZ TITLE CRYSTAL STRUCTURE OF THE MUTANT T159V,V182A OF OROTIDINE 5'- TITLE 2 MONOPHOSPHATE DECARBOXYLASE FROM METHANOBACTERIUM THERMOAUTOTROPHICUM TITLE 3 COMPLEXED WITH THE INHIBITOR BMP COMPND MOL_ID: 1; COMPND 2 MOLECULE: OROTIDINE 5'-PHOSPHATE DECARBOXYLASE; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: OMP DECARBOXYLASE, OMPDCASE, OMPDECASE; COMPND 5 EC: 4.1.1.23; COMPND 6 ENGINEERED: YES; COMPND 7 MUTATION: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: METHANOTHERMOBACTER THERMAUTOTROPHICUS STR. SOURCE 3 DELTA H; SOURCE 4 ORGANISM_TAXID: 187420; SOURCE 5 GENE: PYRF, MTH_129; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562 KEYWDS (BETA-ALPHA)8 BARREL, OROTIDINE 5'-MONOPHOSPHATE DECARBOXYLASE, KEYWDS 2 INHIBITOR BMP, LYASE-LYASE INHIBITOR COMPLEX EXPDTA X-RAY DIFFRACTION AUTHOR A.A.FEDOROV,E.V.FEDOROV,B.DESAI,J.A.GERLT,S.C.ALMO REVDAT 3 13-SEP-23 3QEZ 1 REMARK SEQADV REVDAT 2 19-JUN-13 3QEZ 1 JRNL REVDAT 1 25-JAN-12 3QEZ 0 JRNL AUTH B.J.DESAI,B.M.WOOD,A.A.FEDOROV,E.V.FEDOROV,B.GORYANOVA, JRNL AUTH 2 T.L.AMYES,J.P.RICHARD,S.C.ALMO,J.A.GERLT JRNL TITL CONFORMATIONAL CHANGES IN OROTIDINE 5'-MONOPHOSPHATE JRNL TITL 2 DECARBOXYLASE: A STRUCTURE-BASED EXPLANATION FOR HOW THE JRNL TITL 3 5'-PHOSPHATE GROUP ACTIVATES THE ENZYME. JRNL REF BIOCHEMISTRY V. 51 8665 2012 JRNL REFN ISSN 0006-2960 JRNL PMID 23030629 JRNL DOI 10.1021/BI301188K REMARK 2 REMARK 2 RESOLUTION. 1.54 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE: 1.6.4_486) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 1.54 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.41 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.000 REMARK 3 COMPLETENESS FOR RANGE (%) : 89.4 REMARK 3 NUMBER OF REFLECTIONS : 55241 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.175 REMARK 3 R VALUE (WORKING SET) : 0.173 REMARK 3 FREE R VALUE : 0.206 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 2804 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.4092 - 4.1857 1.00 3025 155 0.1716 0.2012 REMARK 3 2 4.1857 - 3.3234 1.00 2971 159 0.1475 0.1592 REMARK 3 3 3.3234 - 2.9036 1.00 2924 167 0.1554 0.2038 REMARK 3 4 2.9036 - 2.6383 0.99 2942 146 0.1615 0.1962 REMARK 3 5 2.6383 - 2.4492 0.99 2920 150 0.1542 0.1725 REMARK 3 6 2.4492 - 2.3049 0.99 2913 147 0.1554 0.2013 REMARK 3 7 2.3049 - 2.1895 0.99 2889 156 0.1577 0.1831 REMARK 3 8 2.1895 - 2.0942 0.98 2891 153 0.1660 0.2147 REMARK 3 9 2.0942 - 2.0136 0.98 2881 153 0.1704 0.1805 REMARK 3 10 2.0136 - 1.9441 0.98 2854 170 0.1622 0.2190 REMARK 3 11 1.9441 - 1.8833 0.98 2876 156 0.1780 0.2273 REMARK 3 12 1.8833 - 1.8295 0.98 2846 159 0.1830 0.2327 REMARK 3 13 1.8295 - 1.7813 0.98 2848 151 0.1978 0.2490 REMARK 3 14 1.7813 - 1.7379 0.97 2830 160 0.2158 0.2560 REMARK 3 15 1.7379 - 1.6984 0.96 2787 136 0.2399 0.2754 REMARK 3 16 1.6984 - 1.6622 0.90 2634 150 0.2648 0.3064 REMARK 3 17 1.6622 - 1.6290 0.81 2390 108 0.2846 0.3567 REMARK 3 18 1.6290 - 1.5982 0.67 1920 125 0.3328 0.3187 REMARK 3 19 1.5982 - 1.5697 0.51 1484 76 0.3486 0.3861 REMARK 3 20 1.5697 - 1.5431 0.21 612 27 0.3827 0.4313 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.20 REMARK 3 SHRINKAGE RADIUS : 0.95 REMARK 3 K_SOL : 0.42 REMARK 3 B_SOL : 37.13 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.190 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 21.260 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -2.43790 REMARK 3 B22 (A**2) : -0.00320 REMARK 3 B33 (A**2) : 2.44110 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.89720 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.007 3498 REMARK 3 ANGLE : 1.025 4738 REMARK 3 CHIRALITY : 0.068 533 REMARK 3 PLANARITY : 0.006 628 REMARK 3 DIHEDRAL : 12.527 1373 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3QEZ COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 18-FEB-11. REMARK 100 THE DEPOSITION ID IS D_1000063560. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 05-DEC-10 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : NSLS REMARK 200 BEAMLINE : X4A REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.97915 REMARK 200 MONOCHROMATOR : SI 111 CHANNEL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM 4 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : DENZO REMARK 200 DATA SCALING SOFTWARE : SCALEPACK REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 55241 REMARK 200 RESOLUTION RANGE HIGH (A) : 1.350 REMARK 200 RESOLUTION RANGE LOW (A) : 32.410 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 89.4 REMARK 200 DATA REDUNDANCY : NULL REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : NULL REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : NULL REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : NULL REMARK 200 COMPLETENESS FOR SHELL (%) : NULL REMARK 200 DATA REDUNDANCY IN SHELL : NULL REMARK 200 R MERGE FOR SHELL (I) : NULL REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: BALBES REMARK 200 STARTING MODEL: PDB ENTRY 3LTP REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 42.62 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.14 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.2M SODIUM CHLORIDE, 0.1M IMIDAZOLE, REMARK 280 0.4M SODIUM PHOSPHATE/1.6M POTASSIUM PHOSPHATE, PH 8.0, VAPOR REMARK 280 DIFFUSION, HANGING DROP, TEMPERATURE 293.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 32.03500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: DIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: DIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 15310 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -43.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MET A 1 REMARK 465 ARG A 2 REMARK 465 SER A 3 REMARK 465 ARG A 4 REMARK 465 ARG A 5 REMARK 465 VAL A 6 REMARK 465 ASP A 7 REMARK 465 VAL A 8 REMARK 465 ASN A 227 REMARK 465 PRO A 228 REMARK 465 MET B 1 REMARK 465 ARG B 2 REMARK 465 SER B 3 REMARK 465 ARG B 4 REMARK 465 ARG B 5 REMARK 465 VAL B 6 REMARK 465 ASP B 7 REMARK 465 VAL B 8 REMARK 465 ASN B 227 REMARK 465 PRO B 228 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ALA A 74 47.71 -148.49 REMARK 500 THR A 124 -86.15 -95.05 REMARK 500 PHE A 134 -40.55 -132.43 REMARK 500 ASN B 13 15.27 58.80 REMARK 500 LYS B 72 56.39 33.56 REMARK 500 ALA B 74 45.16 -149.97 REMARK 500 THR B 124 -63.17 -102.36 REMARK 500 PHE B 134 -38.91 -130.81 REMARK 500 REMARK 500 REMARK: NULL REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMP A 229 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC2 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE BMP B 229 REMARK 800 REMARK 800 SITE_IDENTIFIER: AC3 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE GOL A 230 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3LTP RELATED DB: PDB REMARK 900 THE WILD TYPE PROTEIN COMPLEXED WITH THE SAME INHIBITOR DBREF 3QEZ A 1 228 UNP O26232 PYRF_METTH 1 228 DBREF 3QEZ B 1 228 UNP O26232 PYRF_METTH 1 228 SEQADV 3QEZ PRO A 101 UNP O26232 ARG 101 CONFLICT SEQADV 3QEZ VAL A 159 UNP O26232 THR 159 ENGINEERED MUTATION SEQADV 3QEZ ALA A 182 UNP O26232 VAL 182 ENGINEERED MUTATION SEQADV 3QEZ PRO B 101 UNP O26232 ARG 101 CONFLICT SEQADV 3QEZ VAL B 159 UNP O26232 THR 159 ENGINEERED MUTATION SEQADV 3QEZ ALA B 182 UNP O26232 VAL 182 ENGINEERED MUTATION SEQRES 1 A 228 MET ARG SER ARG ARG VAL ASP VAL MET ASP VAL MET ASN SEQRES 2 A 228 ARG LEU ILE LEU ALA MET ASP LEU MET ASN ARG ASP ASP SEQRES 3 A 228 ALA LEU ARG VAL THR GLY GLU VAL ARG GLU TYR ILE ASP SEQRES 4 A 228 THR VAL LYS ILE GLY TYR PRO LEU VAL LEU SER GLU GLY SEQRES 5 A 228 MET ASP ILE ILE ALA GLU PHE ARG LYS ARG PHE GLY CYS SEQRES 6 A 228 ARG ILE ILE ALA ASP PHE LYS VAL ALA ASP ILE PRO GLU SEQRES 7 A 228 THR ASN GLU LYS ILE CYS ARG ALA THR PHE LYS ALA GLY SEQRES 8 A 228 ALA ASP ALA ILE ILE VAL HIS GLY PHE PRO GLY ALA ASP SEQRES 9 A 228 SER VAL ARG ALA CYS LEU ASN VAL ALA GLU GLU MET GLY SEQRES 10 A 228 ARG GLU VAL PHE LEU LEU THR GLU MET SER HIS PRO GLY SEQRES 11 A 228 ALA GLU MET PHE ILE GLN GLY ALA ALA ASP GLU ILE ALA SEQRES 12 A 228 ARG MET GLY VAL ASP LEU GLY VAL LYS ASN TYR VAL GLY SEQRES 13 A 228 PRO SER VAL ARG PRO GLU ARG LEU SER ARG LEU ARG GLU SEQRES 14 A 228 ILE ILE GLY GLN ASP SER PHE LEU ILE SER PRO GLY ALA SEQRES 15 A 228 GLY ALA GLN GLY GLY ASP PRO GLY GLU THR LEU ARG PHE SEQRES 16 A 228 ALA ASP ALA ILE ILE VAL GLY ARG SER ILE TYR LEU ALA SEQRES 17 A 228 ASP ASN PRO ALA ALA ALA ALA ALA GLY ILE ILE GLU SER SEQRES 18 A 228 ILE LYS ASP LEU LEU ASN PRO SEQRES 1 B 228 MET ARG SER ARG ARG VAL ASP VAL MET ASP VAL MET ASN SEQRES 2 B 228 ARG LEU ILE LEU ALA MET ASP LEU MET ASN ARG ASP ASP SEQRES 3 B 228 ALA LEU ARG VAL THR GLY GLU VAL ARG GLU TYR ILE ASP SEQRES 4 B 228 THR VAL LYS ILE GLY TYR PRO LEU VAL LEU SER GLU GLY SEQRES 5 B 228 MET ASP ILE ILE ALA GLU PHE ARG LYS ARG PHE GLY CYS SEQRES 6 B 228 ARG ILE ILE ALA ASP PHE LYS VAL ALA ASP ILE PRO GLU SEQRES 7 B 228 THR ASN GLU LYS ILE CYS ARG ALA THR PHE LYS ALA GLY SEQRES 8 B 228 ALA ASP ALA ILE ILE VAL HIS GLY PHE PRO GLY ALA ASP SEQRES 9 B 228 SER VAL ARG ALA CYS LEU ASN VAL ALA GLU GLU MET GLY SEQRES 10 B 228 ARG GLU VAL PHE LEU LEU THR GLU MET SER HIS PRO GLY SEQRES 11 B 228 ALA GLU MET PHE ILE GLN GLY ALA ALA ASP GLU ILE ALA SEQRES 12 B 228 ARG MET GLY VAL ASP LEU GLY VAL LYS ASN TYR VAL GLY SEQRES 13 B 228 PRO SER VAL ARG PRO GLU ARG LEU SER ARG LEU ARG GLU SEQRES 14 B 228 ILE ILE GLY GLN ASP SER PHE LEU ILE SER PRO GLY ALA SEQRES 15 B 228 GLY ALA GLN GLY GLY ASP PRO GLY GLU THR LEU ARG PHE SEQRES 16 B 228 ALA ASP ALA ILE ILE VAL GLY ARG SER ILE TYR LEU ALA SEQRES 17 B 228 ASP ASN PRO ALA ALA ALA ALA ALA GLY ILE ILE GLU SER SEQRES 18 B 228 ILE LYS ASP LEU LEU ASN PRO HET BMP A 229 22 HET GOL A 230 6 HET BMP B 229 22 HETNAM BMP 6-HYDROXYURIDINE-5'-PHOSPHATE HETNAM GOL GLYCEROL HETSYN GOL GLYCERIN; PROPANE-1,2,3-TRIOL FORMUL 3 BMP 2(C9 H13 N2 O10 P) FORMUL 4 GOL C3 H8 O3 FORMUL 6 HOH *191(H2 O) HELIX 1 1 VAL A 11 ASN A 13 5 3 HELIX 2 2 ASN A 23 ARG A 35 1 13 HELIX 3 3 TYR A 45 GLY A 52 1 8 HELIX 4 4 MET A 53 PHE A 63 1 11 HELIX 5 5 ILE A 76 ALA A 90 1 15 HELIX 6 6 GLY A 102 GLY A 117 1 16 HELIX 7 7 HIS A 128 MET A 133 5 6 HELIX 8 8 PHE A 134 GLY A 150 1 17 HELIX 9 9 ARG A 160 GLY A 172 1 13 HELIX 10 10 ASP A 188 LEU A 193 1 6 HELIX 11 11 GLY A 202 LEU A 207 1 6 HELIX 12 12 ASN A 210 ILE A 222 1 13 HELIX 13 13 LYS A 223 LEU A 226 5 4 HELIX 14 14 VAL B 11 ASN B 13 5 3 HELIX 15 15 ASN B 23 ARG B 35 1 13 HELIX 16 16 TYR B 45 GLY B 52 1 8 HELIX 17 17 MET B 53 GLY B 64 1 12 HELIX 18 18 ILE B 76 ALA B 90 1 15 HELIX 19 19 GLY B 102 GLY B 117 1 16 HELIX 20 20 HIS B 128 MET B 133 5 6 HELIX 21 21 PHE B 134 GLY B 150 1 17 HELIX 22 22 ARG B 160 GLY B 172 1 13 HELIX 23 23 ASP B 188 LEU B 193 1 6 HELIX 24 24 GLY B 202 LEU B 207 1 6 HELIX 25 25 ASN B 210 ILE B 222 1 13 HELIX 26 26 LYS B 223 LEU B 226 5 4 SHEET 1 A 9 LEU A 15 MET A 19 0 SHEET 2 A 9 THR A 40 GLY A 44 1 O LYS A 42 N LEU A 17 SHEET 3 A 9 ARG A 66 VAL A 73 1 O ARG A 66 N VAL A 41 SHEET 4 A 9 ALA A 94 HIS A 98 1 O ALA A 94 N ALA A 69 SHEET 5 A 9 GLU A 119 LEU A 123 1 O PHE A 121 N VAL A 97 SHEET 6 A 9 ASN A 153 VAL A 155 1 O ASN A 153 N LEU A 122 SHEET 7 A 9 PHE A 176 SER A 179 1 O PHE A 176 N TYR A 154 SHEET 8 A 9 ALA A 198 VAL A 201 1 O ILE A 200 N SER A 179 SHEET 9 A 9 LEU A 15 MET A 19 1 N ILE A 16 O ILE A 199 SHEET 1 B 9 LEU B 15 MET B 19 0 SHEET 2 B 9 THR B 40 GLY B 44 1 O LYS B 42 N LEU B 17 SHEET 3 B 9 ARG B 66 VAL B 73 1 O ARG B 66 N VAL B 41 SHEET 4 B 9 ALA B 94 HIS B 98 1 O ALA B 94 N ALA B 69 SHEET 5 B 9 GLU B 119 LEU B 123 1 O PHE B 121 N VAL B 97 SHEET 6 B 9 ASN B 153 VAL B 155 1 O ASN B 153 N LEU B 122 SHEET 7 B 9 PHE B 176 PRO B 180 1 O PHE B 176 N TYR B 154 SHEET 8 B 9 ALA B 198 VAL B 201 1 O ILE B 200 N SER B 179 SHEET 9 B 9 LEU B 15 MET B 19 1 N ILE B 16 O ILE B 199 SITE 1 AC1 20 ASP A 20 LYS A 42 ASP A 70 LYS A 72 SITE 2 AC1 20 MET A 126 SER A 127 PRO A 180 GLN A 185 SITE 3 AC1 20 GLY A 202 ARG A 203 HOH A 231 HOH A 233 SITE 4 AC1 20 HOH A 236 HOH A 238 HOH A 242 HOH A 255 SITE 5 AC1 20 HOH A 263 ASP B 75 ILE B 76 THR B 79 SITE 1 AC2 20 ASP A 75 ILE A 76 THR A 79 ASP B 20 SITE 2 AC2 20 LYS B 42 ASP B 70 LYS B 72 MET B 126 SITE 3 AC2 20 SER B 127 PRO B 180 GLN B 185 GLY B 202 SITE 4 AC2 20 ARG B 203 HOH B 231 HOH B 234 HOH B 235 SITE 5 AC2 20 HOH B 237 HOH B 246 HOH B 251 HOH B 267 SITE 1 AC3 7 GLU A 33 ASN A 210 ALA A 212 HOH A 280 SITE 2 AC3 7 HOH A 301 VAL B 159 PRO B 161 CRYST1 59.772 64.070 61.639 90.00 115.46 90.00 P 1 21 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.016730 0.000000 0.007966 0.00000 SCALE2 0.000000 0.015608 0.000000 0.00000 SCALE3 0.000000 0.000000 0.017968 0.00000